[Considerations against the use of EPO in the acute treatment of stroke].
D004921:Erythropoietin / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D011994:Recombinant Proteins; D020521:Stroke / Q000150:complications / Q000188:drug therapy*
D011994:Recombinant Proteins; D004921:Erythropoietin